Nebenwirkungen · Myfenax
Myfenax 250 mg hard capsules · Abschnitt 4.8 · PDF-Seite 15
HOS-209496 · Präparat HOS-154315
Blood and lymphatic disorders Cytopenias, including leukopenia, anaemia, thrombocytopenia and pancytopenia, are known risks associated with mycophenolate mofetil and may lead or contribute to the occurrence of infections and haemorrhages (see section 4.4). Agranulocytosis and neutropenia have been reported; therefore, regular monitoring of patients taking mycophenolate mofetil is advised (see section 4.4). There have been reports of aplastic anaemia and bone marrow failure in patients treated with mycophenolate mofetil, some of which have been fatal.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-10T12:04:00Z · SHA-256 1eac250c72b4f0a4fe3012df5ca65f8295e08fe953b2900f2e41cf74ecbe8efc · Passage 484ea6358930edf0dbbad005b85dade405038cf3f2b7e1723ff20a4eab8f3834 · Zeichen 12949–13505 im Abschnitt